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Abstract
In hepatitis C virus (HCV) infection, morbidity and mortality often result from
extrahepatic disease manifestations. We provide evidence for a role of receptors of
the innate immune system in virally induced inflammation of the endothelium in vitro
and in vivo. Corresponding to the in vitro finding of an HCV-dependent induction of
proinflammatory mediators in endothelial cells, mice treated with poly (I:C) exhibit a
significant reduction in leukocyte rolling velocity, an increase in leukocyte adhesion
to the vessel wall and an increased extravasation of leukocytes. HCV directly
promotes activation, adhesion and infiltration of inflammatory cells into the vessel
wall by activation of endothelial viral receptors. Poly (I:C) induces the expression of
TLR3 in vivo and hereby allows for amplification of all of the aforementioned
responses upon viral infection. Proinflammatory effects of viral RNA are specifically
mediated by TLR3 and significantly enhanced by tumor necrosis factor alpha
(TNFa). HCV-RNA induces the endothelial expression of TNFa and TNFa receptor
subtype 2 and we provide evidence that leucocyte adhesion and transmigration in
response to activation of viral RNA receptors seem to depend on expression of
functional TNFR2. Our results demonstrate that endothelial cells actively participate
in immune mediated vascular inflammation caused by viral infections.
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Introduction
More than 170 million people worldwide are chronically infected with the
hepatitis C virus (HCV), which is responsible for over 1 million deaths resulting
from cirrhosis and primary liver cancers [1]. Besides liver disease, HCV infection
is frequently associated with a variety of autoimmune phenomenona with
extrahepatic manifestations including cryoglobulinemia [2, 3], renal disease [4]
and vasculitis [2, 3, 5, 6, 7]. Extrahepatic manifestations are often severe and
contribute significantly to morbidity and mortality. We have previously shown
the impact of activation of viral receptors of the innate immune system,
particularly TLR3, on HCV-associated glomerulonephritis [8, 9, 10]. Here we
provide evidence for a role of receptors of the innate immune system in virally
induced inflammation of the endothelium.
Toll-like receptors (TLR) are an essential part of the innate immune system. TLR
recognize conserved pathogen-associated molecular patterns (PAMP) and are
expressed on immune cells but also on a number of non-immune cells. TLR
recognize molecular patterns associated with microbial pathogens and induce an
immune response [11]. TLR3 specifically binds dsRNA of viral origin as well as
polyriboinosinic:polyribocytidylic acid (poly (I:C)), a synthetic analogue of viral
dsRNA [12]. Besides TLR3, the helicase retinoic acid-inducible gene I (RIG-I) and
melanoma differentiation-associated gene 5 (MDA5) may also act as sensors of viral
infections by recognition of viral dsRNA [13, 14, 15]. Here we show that both poly
(I:C) and HCV-RNA isolated from patients infected with the Hepatitis C virus
induce the endothelial expression of proinflammatory cytokines, chemokines and
type I interferons as well as adhesion molecules. These effects of viral RNA on
endothelial cells are specifically mediated by TLR3. Furthermore, we demonstrate
an immunomodulatory role of the TNFa/TNF receptor system in HCV-associated
vasculitis with a potential impact on the development of new therapeutic strategies.
Materials and Methods
Human microvascular endothelial cells (HMEC) were provided by Ades et al. [16]
and cultured in M199 medium supplemented with 10% FCS, 10% endothelial
growth medium (PromoCell, Germany) and 1% penicillin/streptomycin. Human
umbilical vein endothelial cells (HUVEC) were isolated and cultured as described
previously [17]. The procedure was approved by the university ethics review
board (Ethikkommission der Medizinischen Fakultät der Ludwig-Maximilians-
Universität). Written informed consent for the collection and generation of the
cell lines was obtained. Cytokines were used in a concentration of 25 ng/ml
(TNFa), 10 ng/ml (IL-1b) and 20 ng/ml (IFN-c). For cytokine prestimulation
experiments, HMEC were incubated with a combination of TNFa, IL-1b and
IFN-c for 12 hours, washed with PBS, left in culture medium for 6 hours and
washed again with PBS. Subsequently, HMEC were incubated with growth
medium (control) or medium containing poly (I:C). For poly (I:C) prestimula-
tion experiments, HMEC were incubated with poly (I:C) (10 mg/ml) for 24 hours,
Hepatitis C and Endothelium
PLOS ONE | DOI:10.1371/journal.pone.0113351 November 24, 2014 2 / 23
then washed with PBS, and subsequently incubated with TNFa for different time
intervals as indicated. For each stimulation experiment controls were performed
in parallel using culture medium alone.
Animals
Animal experiments were performed in wild-type (WT) and TNFa receptor
subtype 2-deficient (TNFR2-/-) C57BL/6 mice. WT mice were purchased from
Charles River (Germany) and TNFR22/2 mice were originally obtained from the
Jackson Laboratory (USA). Surgical procedures were performed under short-term
anesthesia induced by a single intraperitoneal injection of midazolam 3 mg/kg
(Ratiopharm, Germany), fentanyl 0.03 mg/kg (CuraMED Pharma, Germany),
and medetomidinhydrochloride 0.3 mg/kg (Pfizer, Germany; produced by Orion
Pharma, Finland) diluted in 0.9% NaCl. After the experiments, the animals were
killed by injection of an overdose (2 g/kg) of sodium pentobarbital (Merial,
Germany). All experiments were conducted in accordance with the German
animal protection law and approved by the district government of Upper Bavaria
(approval reference number AZ 55.2-1-54-2531-162-08) and the Institutional
Animal Care and Use Committee (IACUC). The investigation conforms to
Directive 2010/63/EU of the European Parliament. Due to the narrow species
restriction of HCV which allows infection of humans and chimpanzees only and
the resulting lack of non-chimeric small animal models which would allow for
direct studies of hepatitis C virus (HCV), stimulation experiments were
performed with intraperitoneal injection of poly (I:C) as indicated.
Mouse blood cell counts
Mouse blood was collected via a carotid catheter and EDTA used as anticoagulant.
Blood cell counts were measured using a Beckmann Coulter Counter (Beckman
Coulter, Germany).
Spleen weight
Immediately after scarification of the animals the spleen was isolated and
separated from the surrounding connective tissue. Weight of the organ was
measured using a special accuracy weighing machine from Acculab (Sartorius AG,
Germany) and normalized to the body weight of the respective animal.
Intravital microscopy in the mouse cremaster muscle
Leukocyte-endothelium-interaction in vivo was assessed in postcapillary venules
of the mouse cremaster muscle. Mice were anesthetized and the right carotid
artery was cannulated for administration of fluorescent microspheres to
determine blood flow velocity. The cremaster muscle was prepared for intravital
microscopy as originally described by Baez et al [18]. Throughout the procedure
the muscle was kept warm and moist by superfusion of warm buffered saline. In the
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applied in vivo model, leukocyte adhesion in cremaster muscle venules is induced
by the surgical preparation and observed for up to 45 minutes after exteriorization
of the cremaster muscle. Intravital microscopy was performed using a Zeiss
Axiotech Vario microscope (Zeiss, Germany) and leukocyte-endothelium-interac-
tion was analyzed in 5–6 postcapillary venules and recorded using a digital camera
(AxioCam HSm, Zeiss Germany). For measurement of blood flow velocity, green
fluorescent microspheres (1 mm diameter; Polysciences, Germany) were injected via
the carotid artery catheter, and their passage through the vessels of interest was
recorded using the respective fluorescent filter cube. Blood flow was calculated from
the length of a single microsphere in a single image with defined exposure time.
Rolling leukocytes were defined as those moving slower than the blood flow and
their velocity was calculated from the distance they were moving in a defined time
frame. Firmly adherent cells were determined as those resting in vessel for more
than 30 seconds of observation and related to the luminal surface of the observed
vessel part. For investigation of extravasated leukocytes, whole mounts of the
Cremaster muscles were performed immediately after sacrifying the animals and
Giemsa-staining was used to label perivascular leukocytes.
Quantitative reverse transcriptase-polymerase chain reaction
(RT-PCR) analysis
RT-PCR analysis was done as described [8]. Sequences were used as indicated or pre-
developed Taq Man assay reagents or primers and probes were purchased from
Applied Biosystems: NM_003265.2, HS00152933_m1 (human TLR3), NM_014314.3,
Hs00204833_m1 (human RIG-I), NM_022168.2, Hs0170332_m1 (human MDA5),
NM_000600.3, Hs00174131_m1 (human IL-6), NM_000584.2, Hs00174103_m1
(human IL-8), NM_002985.2, Hs00174575_m1 (human RANTES), NM_002982.3,
Hs00234140_m1, (human MCP-1), NM_001565.2, Hs00171042_m1 (human IP-10),
FP: CCT TCC TCC TGT CTG ATG GA; RP: ACT GGT TGC CAT CAA ACT CC; T1:
6FAM CAG ACA TGA CTT TGG ATT TCC CCA GG (human IFN-a),
NM_002176.2, Hs00277188_s1 (human IFN-b), NM_172210.2, NM_172211.2,
NM_172212.2, NM_000757.4 (human MCSF), NM_000201.2, Hs00164932_m1,
(human ICAM-1), NM_001078.3, NM_001199834.1, NM_080682.2,
Hs00365486_m1 (human VCAM-1), NM_000594.2, Hs00174128_m1 (human
TNFa), NM_001065.3, Hs00533560_m1 (human TNFR1), NM_001066.2,
Hs00153550_m1 (human TNFR2) and M33197 (human GAPDH).
ELISA
ELISA for IL-6, IL-8 and IP-10 were performed on cell culture supernatants using
commercial assay kits (R&D Systems, USA) and following providers instructions.
Flow Cytometry
ICAM-1, VCAM-1, E- and P-Selectin located to the cell surface were measured
after fixation with 4% formaldehyde and staining with anti-ICAM-1-FITC,
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anti-VCAM-1-FITC, anti-p-selectin-RPE and anti-Tissue-factor-FITC or the
corresponding FITC- or RPE-labeled negative controls by a FACSCanto II flow
cytometer (Becton Dickinson, USA). Data were analyzed using FACSDiva
software (Becton Dickinson, USA). Antibodies and respective negative controls
were purchased from Biozol (Germany), Southern Biotech (USA) or R&D
Systems (USA) respectively.
Western blot
Western blot analysis was performed as previously described [19]. HMEC were
grown to subconfluence and starved for 24 hours in cell medium containing 1%
FCS prior to stimulation with poly (I:C) for the indicated time intervals. After
washing with PBS the cells were lysed on ice using cell lysis buffer (Cell Signaling
Technology, USA) and protein concentration was determined using BCA
(bicinchoninic acid) protein assay reagent kit according to the manufacturer’s
protocol. Equal amounts of protein were separated by gel electrophoresis (SDS-
PAGE) and blotted onto a nitrocellulose membrane. Membranes were blocked by
incubation 5% (w/v) BSA in TBSt (Tris-buffered saline with Tween) for
30 minutes prior to incubation with a rabbit anti-human-TNFR2-antibody (Cell
signaling Technology, USA) at 4 C̊ overnight. After washing with TBSt the
membrane was incubated with a horseradish peroxidase conjugated secondary
antibody for 1 hour at room temperature. Enzymatic activity was detected with a
chemiluminescence detection kit according to the supplier’s protocol and
recorded with a digital camera (Hamamatsu). GAPDH served as loading control.
Densiometric analysis of the blots was performed digitally using WASABI
Software.
Gene expression in vivo
Animal experiments were performed in wildtype (WT) or TNFa receptor subtype
2 deficient C57BL/6 mice. For gene expression studies in vivo, poly (I:C) or sham
treated mice were sacrified and lungs, kidneys, aorta and cremaster muscle were
immediately isolated and homogenized by adding ceramic microspheres to the
tissue and mixing with a CapMix (3 M ESPE, Germany). RNA isolation was then
performed using a commercially available RNA isolation kit (PeqLab, Germany).
Samples were kept frozen at 220 C̊ until further analysis. For real-time PCR,
commercially available pre-developed TaqMan reagents were used for the mouse
target genes TLR3 and TNFR2. GAPDH was used as reference housekeeping gene.
All measurements were performed in duplicates.
Knockdown of gene expression with short interfering RNA (siRNA)
Predesigned siRNAs specific for TLR3, RIG-I and MDA5 were purchased from
Ambion (Japan). Transfection of cells with siRNA was performed as described
before [13]. Scrambled siRNA was used as the nonspecific negative control of
siRNA.
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Proliferation assays
To assess the proliferative activity of HMEC, MTT assays were performed as
described [20]. Aliquots of 56103 cells in 100 ml culture medium were cultured in
96-well microtiter plates for 24 hours under standard conditions to yield firmly
attached and stably growing cells. After discarding the supernatants, cells were
incubated with poly (I:C) as indicated. After removal of the supernatant, 50 ml of
a 1 mg/ml solution of MTT (Sigma-Aldrich, USA) were added for 3 hours at
37 C̊. Then, formazan crystals were dissolved by the addition of 50 ml isopropanol.
Absorbance was measured at 570 to 690 nm as a reference using a Dynatech
MR7000 ELISA reader (Denkendorf, Germany).
Preparation of HCV RNA
HCV RNA containing cryoprecipitates were isolated from a patient with a HCV
associated MC with a high viral load during routine plasmapheresis treatment and
centrifuged. as described previously [10] The concentration of HCV used for
stimulation was 100 or 2006106 geq/ml, confirmed by RT-PCR. For HCV
stimulation, confluent HMEC in 6-well plates were used; once the virus was
added, the plates were centrifuged at 1000 g for 45 min to allow efficient viral
infection. Subsequent stimulation was performed as indicated.
Histology
Immediately after sacrificing the animals organs were isolated, removed from the
surrounding connective tissue and stored in paraformaldehyde until further
analysis [21].
Statistical analysis
Values are provided as mean ¡ SD. Statistical analysis was performed by the
unpaired t test if applicable or by the ANOVA-analysis. Significant differences in
expression levels are indicated for p values ,0.05 (*) or 0.01 (**), respectively.
Results
Expression of viral RNA receptors of the innate immune system on
human microvascular endothelial cells (HMEC)
We examined cultured HMEC for the expression of the viral dsRNA sensing
receptors TLR3, RIG-I and MDA5. RNA was prepared from cells grown under
standard conditions as well as from cells that had been stimulated with a
combination of the cytokines TNFa, IL-1b and IFN-c for 12 hours to simulate a
proinflammatory milieu as would occur during immune-mediated vasculitis. By
RT-PCR, specific products for TLR3, RIG-I and MDA5 mRNA were amplified
from both unstimulated and stimulated cells. The basal expression for TLR3, RIG-
I and MDA5 was induced by the cytokine combination (Figure 1A–C). In order to
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test the effect of ligand binding on the expression of viral receptors, HMEC were
stimulated with poly (I:C) (10 mg/ml) mimicking viral RNA for different time
intervals (3, 6, 9, 12, 24, 48 hours). Poly (I:C) led to a time dependent increase in
the expression of viral receptors with a maximum after 12 hours (Figure 1D–F).
The time-dependent effect of poly (I:C) on TLR3 protein synthesis was
demonstrated by western blot (Figure 1M). Stimulation of HMEC with different
concentrations (0.5, 5, 10 mg/ml) of poly (I:C) for 12 hours led to a
concentration-dependent increase in the expression of TLR3, RIG-I and MDA5
(Figure 1G-I). Furthermore, HMEC were cultivated under basal conditions or
pretreated with a combination of the proinflammatory cytokines TNF-a, IL-1b
and IFN-c as described, washed and then incubated with poly (I:C) (10 mg/ml) for
12 hours. mRNA levels of TLR3, RIG-I and MDA5 were measured. Again, the
cytokine combination led to an enhanced expression of the viral receptors TLR3,
RIG-I and MDA5; the effect of poly (I:C) on the expression of TLR3 and MDA5
was amplified in cells pretreated with proinflammatory cytokines. (Figure 1J–L).
Additionally, HMEC were screened for mRNA expression of TLR1 through
TLR10 by RT-PCR under basal conditions and after cytokine pretreatment.
HMEC show a robust expression of TLR1, TLR4 and TLR6 without significant
changes after stimulation with proinflammatory cytokines. Under basal condi-
tions, no relevant expression was found for TLR2 and TLR7, but these receptors
were inducible by the cytokine combination. The expression for TLR9, both basal
and after stimulation, was too low to allow for evaluation. No expression was
found for TLR5, TLR8 and TLR10 under any condition (results not shown).
Effect of poly (I:C) stimulation on the expression of selected
cytokines and chemokines, type I interferons, MCSF and adhesion
molecules
HMEC were stimulated with poly (I:C) (10 mg/ml) for different time intervals (3,
6, 9, 12, 24, 48 hours) and the expression of selected proinflammatory cytokines
and chemokines was analyzed by RT-PCR. Poly (I:C) increased the mRNA
expression of IL-6, IL-8, IP-10, RANTES and MCP-1 in a time dependent manner
with a maximum after 12 hours of stimulation time (Figure S1A, C, E, G, H). On
protein level, this effect was confirmed for IL-6, IL-8 and IP-10 by ELISA (Figure
S1B, D, F).
In contrast to the basal expression of IFN-a on HMEC, which was not
significantly changed by incubation with poly (I:C), the expression of IFN-b was
early and stably increased from 3 up to 12 hours of poly (I:C) stimulation. (Figure
S1I, J). MCSF expression was elevated over the whole poly (I:C) stimulation
interval from 3 to 48 hours, with a maximum after 12 hours stimulation (Figure
S1K). mRNA expression of ICAM-1 and VCAM-1 were increased from 3 to
24 hours poly (I:C) stimulation, also with a maximum after 12 hours (figure S1L,
N); a concordant increase in protein synthesis of these adhesion molecules was
confirmed by FACS (Figure S1M, O). Additionally, the surface expression of E-
selectin and P-selectin was analyzed in human umbilical vein endothelial cells
Hepatitis C and Endothelium
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(HUVEC) by FACS. When HUVEC were stimulated with poly (I:C) for 24 hours,
P-selectin expression was significantly increased, whereas the expression of E-
selectin was increased from 24 to 48 hours of poly (I:C) treatment (Figure S1P,
Q). The stimulating effect of poly (I:C) was also reproducible in HUVEC for the
selected targets IL-6 and ICAM-1 (data not shown).
Effect of poly (I:C) on endothelial cell proliferation
Proliferation of HMEC in response to poly (I:C) was assessed by the MTT
proliferation assay as described. When HMEC were stimulated with poly (I:C)
(10 mg/ml) for different time intervals (3, 6, 9, 12, 24, 48 hours), cell proliferation
was significantly decreased from 6 up to 48 hours stimulation time (Figure S1R).
Effect of HCV-RNA containing cryoprecipitates on the expression
of cytokines, chemokines and adhesion molecules
As we hypothesize a role of receptors of the innate immune system in Hepatitis C
associated vascular inflammation and as we could demonstrate a role of TLR3 in
the mediation of endothelial inflammation and production of adhesion molecules,
we next tested the effect of a stimulation with HCV-RNA containing
cryoprecipitates from a patient with an Hepatitis C-associated cryoglobulinemia
on the expression of selected cytokines, chemokines and adhesion molecules.
Cryoprecipitates were isolated as described in Materials and Methods and HMEC
were stimulated with different concentrations (1006106 geq/ml, 2006106 geq/
ml) of HCV RNA for 12 hours. HCV RNA containing cryoprecipitates increased
the mRNA expression of IL-6, IL-8 and ICAM-1 (Figure 2A, C, E, G). A
concordant increase in protein synthesis was confirmed by ELISA for IL-6, IL-8
and IP-10 (Figure 2B, D, F).
Effect of transfection with siRNA specific for TLR3, RIG-I and MDA5
on poly (I:C) induced gene expression
To define the viral receptor which mediates the poly (I:C)-dependent induction of
the dsDNS sensing receptors, HMEC were transfected with siRNA specific for
TLR3, RIG-I and MDA5 as described and stimulated with poly (I:C) (10 mg/ml)
for 12 hours. Expression of TLR3, RIG-I and MDA5 was measured by RT-PCR.
The poly (I:C)-dependent induction of the expression of TLR3 was significantly
Figure 1. Expression of viral receptors in HMEC. HMEC were stimulated with (Comb) and without (Basal) a combination of the proinflammatory cytokines
TNFa, IL-1b and IFN-c for 12 hours. By RT-PCR, specific products for TLR3 (A), RIG-I (B) and MDA5 (C) mRNA were amplified from both unstimulated and
stimulated cells. HMEC were stimulated without and with poly (I:C) (10 mg/ml) for different time intervals (3, 6, 9, 12, 24, 48 hours) and mRNA expression of
TLR3 (D), RIG-I (E) and MDA5 (F) was analyzed by RT-PCR. Time-dependent effect of poly (I:C) on TLR3 protein expression was confirmed by western blot
(M). HMEC were stimulated without (Basal) and with different concentrations (0.5, 5, 10 mg/ml) of poly (I:C) for 12 hours and expression of TLR3 (G), RIG-I
(H) and MDA5 (I) was measured by RT-PCR. HMEC were pretreated under basal or cytokine combination conditions (Comb) as described in Methods and
after washing incubated with or without poly (I:C) (10 mg/ml) for 12 hours. Expression of TLR3 (J), RIG-I (K) and MDA5 (L) was analyzed by RT-PCR.
Results are given as means ¡ SD of three experiments done in parallel for each condition and rRNA served as the reference gene. Comparable results
were obtained in two series of independent experiments. Statistically significant differences to the control are depicted with * 5p#0.05.
doi:10.1371/journal.pone.0113351.g001
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blocked only by siRNA specific for TLR3; the poly(I:C)-dependent induction of
RIG-I was reduced by transfection with siRNA specific for TLR3 and RIG-I, and
the expression of MDA5 was reduced by the knockdown of any of the three RNA
receptors (Figure S2A–C). To identify the viral receptor responsible for the
induction of cytokines, chemokines and adhesion molecules by poly (I:C), HMEC
were transfected with siRNA specific for TLR3, RIG-I and MDA5 and stimulated
with poly (I:C) (10 mg/ml) for 12 hours. Poly (I:C) increased the expression of the
selected proinflammatory genes IL-6, RANTES, MCP-1, IP-10, IFN-b and
VCAM-1, and these effects were significantly reduced by transfection of HMEC
with siRNA specific for TLR3; transfection with siRNA specific for RIG-I, MDA5
and with negative controls containing unspecific RNA had no effect (Figure S2D-
I).
Effect of poly (I:C) on vascular inflammation in vivo
To test whether poly (I:C)-induced upregulation of inflammatory cytokines and
adhesion molecules on endothelial cells in vitro translates into vascular
inflammation in vivo, C57Bl/6 mice were systemically treated with poly (I:C)
(200 mg i.p.). After 48 h, the white blood cell count was significantly decreased
compared to controls, which was due to a decrease in lymphocyte counts
(Figure 3A, B). Leukocyte rolling and adhesion were observed by intravital
microscopy in trauma-stimulated cremaster muscle venules. While hemodynamic
and microvascular parameters were similar to sham treated controls, leukocyte
rolling velocity was significantly slower in the poly (I:C) treated group
(Figure 3C). Additionally, poly (I:C) increased the fraction of leukocytes adhering
to the vessel wall and consecutively led to a significantly increased extravasation of
leukocytes as detected in whole mounts of cremaster muscles after sacrificing the
animals (Figure 3D, E). Repeated treatment of animals with poly (I:C) (100 mg
every other day for 2 weeks) resulted in a significantly increased leukocyte
adherence in the lung tissue (Figure 3F) as well as in prominent splenomegaly
(Figure 3G).
Effect of TNFa on the expression of cytokines, chemokines, MCSF
and adhesion molecules
As we have previously demonstrated a role for TNFa and its receptors in hepatitis
C virus-associated glomerulonephritis and vascular thrombosis [10, 22] and as we
Figure 2. Effect of HCV RNA containing cryoprecipitates on the expression of cytokines, chemokines
and adhesion molecules. HMEC were stimulated with different concentrations (1006106 geq/ml,
2006106 geq/ml) of HCV RNA containing cryoprecipitates (HCV) for 12 hours and mRNA expression of
selected cytokines and chemokines IL-6 (A), IL-8 (C), IP-10 (E) and adhesion molecule ICAM-1 (G) was
analyzed by RT-PCR. Protein synthesis of IL-6 (B), IL-8 (D) and IP-10 (F) was also confirmed by ELISA.
Results are given as means ¡ SD of three experiments done in parallel for each condition and rRNA served
as the reference gene. Comparable results were obtained in two series of independent experiments.
Statistically significant differences to the control are depicted with * 5p#0.05.
doi:10.1371/journal.pone.0113351.g002
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Figure 3. Effect of poly (I:C) on vascular inflammation in vivo. C57Bl/6 mice were systemically treated with poly (I:C) (200 mg i.p.) and white blood cell
counts were perfomed after 48 hours (A, B). At the same time leukocyte rolling (C) and adhesion (D) in vivo as well as extravasation of leukocytes (E) were
investigated in postcapillary venules of the mouse cremaster muscle by intravital microscopy or in cremaster muscle whole mounts respectively. After
repeated ploly (I:C) treatment (100 mg every other day for 2 weeks) vascular inflammation was investigated in lung tissue as described (F) and spleen weight
was measured (G). Results are given as means ¡ SEM (n54–6 animals). Statistically significant differences to the control are depicted with * 5p#0.05.
doi:10.1371/journal.pone.0113351.g003
Hepatitis C and Endothelium
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therefore hypothesize a predominant role of the TNFa/TNF receptor system in
vascular inflammation, we now tested the effect of TNFa on the expression of
selected proinflammatory cytokines, chemokines, MCSF and adhesion molecules.
Stimulation of HMEC with TNFa for different time intervals (3, 6, 9, 12,
24 hours) led to a significant increase in the expression of IL-6, IL-8, IP-10
RANTES, MCP-1, IP-10, IFN-b, MCSF, ICAM-1 and VCAM-1 from 3 to
24 hours, with a maximum after a 3 hours’ stimulation time for IL-6 and IL-8,
after 12 hours for IP-10 and RANTES after 24 hours for IFN-b (figure S3A, C, E,
G, I). mRNA expression of MCP-1, MCSF, ICAM-1 and VCAM-1 was stably
increased from 3 to 24 hours of TNFa stimulation (Figure S3H, J, K, L). Increased
protein levels of IL-6, IL-8 and IP-10 (Figure S3B, D, F) and ICAM-1 (data not
shown) were confirmed by ELISA or FACS.
Effect of poly (I:C) stimulation and HCV RNA containing
cryoprecipitates on the expression of TNFa and TNF receptors
Still based on the hypothesis of a predominant role of the TNFa/TNF receptor
system in immune-mediated vascular inflammation, we then tested the effect of
activation of viral receptors on the expression of TNFa and TNF receptors in
HMEC. HMEC were stimulated with poly (I:C) (10 mg/ml) for different time
intervals (3, 6, 9, 12, 24, 48 hours) and the expression of TNFa and the TNF
receptor subtypes TNF receptor 1 (TNFR1) and TNF receptor 2 (TNFR2) was
analyzed by RT-PCR. Poly (I:C) stimulation increased the expression of TNFa
from 3 to 12 hours of poly (I:C) stimulation time, with a maximum after
12 hours. Knockdown experiments with siRNA specific for TLR3, RIG-I and
MDA5 showed this effect to be TLR3-dependent (Figure 4A, D). Poly (I:C)
stimulation showed a tendency to early enhance the expression of TNFR1, which
though did not reach statistical significance (Figure 4B). TNFR2 mRNA
expression was significantly increased after 6, 9 and 12 hours of poly (I:C)
stimulation (Figure 4C), an effect which was also shown to be TLR3-dependent
and confirmed on protein level by western blot (Figure 4E, F). The stimulating
effect of poly (I:C) on TNFR2 was reproducible in HUVEC (data not shown).
Furthermore, stimulation with HCV-RNA containing cryoprecipitates in different
concentrations (1006106 geq/ml, 2006106 geq/ml), which had been isolated
from a patient with HCV-associated cryoglobulinemia, for 12 hours led to a
significant increase in the expression of TNFR2 (Figure 4G).
Effect of TNFa on the expression of TNF receptors and viral
receptors
To test for an amplification of proinflammatory responses upon activation of viral
receptors by TNFa itself, HMEC were stimulated with TNFa for different time
intervals (3, 6, 9, 12, 24 hours) and the expression of TNFa, the TNF receptors
TNFR1 and TNFR2 as well as of the viral receptors TLR3, RIG-I and MDA5 was
analyzed by RT-PCR. TNFa led to an increase in the expression of TNFa and
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TNFR2 from 3 to 24 hours respectively 9 to 12 hours of stimulation time, but had
no effect on the basal expression of TNFR1 (Figure 4H–J). Expression levels of
TLR3 were significantly increased only after a 24 hours’ stimulation with TNFa,
whereas the expression of RIG-I and MDA5 was already increased after 6 hours
and reached a maximum after 24 hours of TNFa stimulation (Figure 4K-M).
Amplification of poly (I:C) dependent induction of viral receptors
and TNF receptors 2 by TNFa
To test for an additionally permissive effect of TNFa on the ligand dependent
induction of the dsRNA sensing viral receptors TLR3, RIG-I and MDA5 as well as
on TNFR2, HMEC were incubated with poly (I:C) (10 mg/ml) for 24 hours and
then incubated in culture medium or stimulated with TNFa for different time
intervals (6, 12, 24 hours). As expected, the expression of TLR3, RIG-I and MDA5
was increased by poly (I:C), and the subsequent incubation with TNFa further
induced expression levels of all these viral receptors and of TNFR2 (Figure S4A–
D).
Amplification of poly (I:C) dependent induction of cytokines,
chemokines and adhesion molecules by TNFa
To test whether TNFa would also directly amplify endothelial inflammatory
responses seen upon activation of viral receptors by poly (I:C), HMEC were
stimulated by poly (I:C) (10 mg/ml) for 24 hours and subsequently incubated with
TNFa for different time intervals (6, 12, 24 hours). Poly (I:C) led to an increase in
the expression of IL-6, IL-8, IP-10, RANTES, IFN-b and MCSF (Figure 5A, C, E,
G, I, J), whereas MCP-1, ICAM-1 and VCAM-1 were not significantly increased
by stimulation with poly (I:C) alone (figure 5H, K, L). The stimulatory effects of
poly (I:C) were significantly potentiated by TNFa treatment for 6, 12 and
24 hours. A parallel increase in protein synthesis of IL-6, IL-8 and IP-10 was
confirmed by ELISA (Figure 5B, D, H).
Role of TNFR2 in poly (I:C) induced vascular inflammation
We next investigated the expression of TLR3 and TNFR2 upon activation of viral
RNA receptors in organ lysates of wild-type (WT) and TNFa receptor subtype 2-
Figure 4. Effect of poly (I:C) and HCV RNA containing cryoprecipitates on the expression of TNFa and TNF receptors; effect of TNFa on the
expression of TNF receptors and viral receptors. HMEC were stimulated without (basal) and with poly (I:C) (10 mg/ml) for different time intervals (3, 6, 9,
12, 24, 48 hours) and expression of TNFa (A), TNF receptor 1 (TNFR1) (B) and TNF receptor 2 (TNFR2) (C) was analyzed by RT-PCR. (D, E) HMEC were
transfected with siRNA for TLR3, RIG-I and MDA5 as well as unspecific RNA as negative control as described in Materials and Methods and stimulated with
poly (I:C) (10 mg/ml) for 12 hours. Expression of TNFa (D) and TNFR2 (E) was analyzed by RT-PCR. Protein expression of TNFR2 after different time
intervals of poly (I:C) stimulation (3, 6, 9, 12, 48 hours) was confirmed by western blot (F). HMEC were stimulated with different concentrations
(1006106 geq/ml, 2006106 geq/ml) of HCV RNA containing cryoprecipitates for 12 hours and mRNA expression of TNFR2 (G) was analyzed by RT-PCR.
HMEC were stimulated with TNFa for different time intervals (3, 6, 9, 12, 24 hours) and expression of TNFa (H), TNFR1 (I), TNFR2 (J), TLR3 (K), RIG-I (L)
and MDA5 (M) was analyzed by RT-PCR. Results are given as means ¡ SD of three experiments done in parallel for each condition and rRNA served as
the reference gene. Comparable results were obtained in two series of independent experiments. Statistically significant differences to the control are
depicted with * 5p#0.05.
doi:10.1371/journal.pone.0113351.g004
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deficient (TNFR2-/-) C57BL/6 mice. WT or TNFR2-/- mice were treated with poly
(I:C) 200 mg i.p. as described and TLR3 and TNFR2 mRNA levels were analyzed
after 24 and 48 hours. After 24 hours, poly (I:C) had no effect on TLR3 or TNFR2
expression in lung tissue of WT or TNFR2-/- mice (data not shown), whereas after
48 hours poly (I:C) upregulated TLR3 expression in lung, kidney, aorta and
cremaster muscle of both WT and TNFR2-/- mice (Figure 6A). Moreover, after
48 hours of poly (I:C) treatment, a significant increase in the expression of
TNFR2 in lung, kidney, aorta and cremaster muscle of WT mice was observed;
obviously, no expression of TNFR2 was found in TNFR2-/- mice (Figure 6B). Poly
(I:C) decreased the white blood cell count in both WT and TNFR2-/- mice
(Figure 6C). The poly (I:C)-dependent increase in rolling leukocytes in cremaster
Figure 5. Amplification of poly (I:C)-mediated induction of cytokines, chemokines and adhesion molecules by TNFa. HMEC were grown in culture
medium for 24 hours and additionally incubated in medium (basal) for different time intervals (6, 12, 24 hours) or grown in culture medium for 24 hours and
additionally incubated with TNFa (TNFa) for different time intervals (6, 12, 24 hours) or incubated with poly (I:C) for 24 hours and then grown in medium
(poly (I:C)) or stimulated with TNFa (poly (I:C) + TNFa) for different time intervals (6, 12, 24 hours). mRNA expression of selected cytokines and chemokines
IL-6 (A), IL-8 (C), IP-10 (E), RANTES (G), MCP-1 (H), IFN-b (I), MCSF (J), ICAM-1 (K) and VCAM-1 (L) was analyzed by RT-PCR. Protein synthesis of
selected targets IL-6 (B), IL-8 (D) and IP-10 (F) was also confirmed by ELISA. Results are given as means ¡ SD of three experiments done in parallel for
each condition and rRNA served as the reference gene. Comparable results were obtained in two series of independent experiments. Statistically significant
differences to the control are depicted with *5p#0.05, **5p#0.01.
doi:10.1371/journal.pone.0113351.g005
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muscle venules and in leukocyte adherence in vivo reached statistical significance
only in WT, not in TNFR2-/- mice (Figure 6D, E).
Discussion
Hepatitis C virus (HCV)-related systemic vasculitis is a severe complication of
infection with HCV and causes significant morbidity and mortality [23]. HCV-
associated vasculitis has been described to occur both in the presence and in the
absence of mixed cryoglobulinemia (MC) [24], and up to 10% of patients with
MC develop systemic vasculitis [6, 7]. From the patients found to have MC, more
than 80% are infected by HCV [2, 3, 5, 6]. During disease course, immune
complexes containing viral RNA reach the small and medium-sized arteries and
veins and deposit in the vessel walls. The clinical features of HCV-associated
vasculitis not only include the classical triad of purpura, arthralgias and myalgias,
but also prognostically severe forms of glomerulonephritis, lymphoproliferative
disorders, neuropathies and skin ulcerations as well as other dermatologic
conditions [25].
Figure 6. Role of TNFR2 in poly (I:C) induced vascular inflammation. WTand TNFR2-/- mice were sham treated or treated with poly (I:C) 200 mg i.p. as
described and expression of TLR3 and TNFR2 was analyzed by RT-PCR. Expression of TLR3 (A) and TNFR2 (B) was measured in lung, kidney, aorta and
cremaster muscle tissue after 48 hours. At the same time point white blood cell counts were performed and effects of poly (I:C) on trauma-induced leukocyte
rolling and adherence in vivo were investigated in cremaster muscle venules by intravital microscopy (C–E). Statistically significant differences to the control
are depicted with * 5p#0.05.
doi:10.1371/journal.pone.0113351.g006
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Cytokines and chemokines play a central role in the immune response to HCV
as they mediate antiviral and proinflammatory effects in immune as well as
primarily non-immune cell types [26, 27, 28]. In the clinical setting, serum levels
of proinflammatory mediators including IL-6 and TNFa have been shown to be
increased in patients with an HCV-associated MC and are found to be particularly
elevated during active vasculitis [29]. Furthermore, the emergence of severe
vasculitis due to HCV-associated MC was shown to be dependent on the
induction of adhesion molecules including VCAM-1 and ICAM-1, both involved
in mononuclear respectively polymorphonuclear and mononuclear cell recruit-
ment during vasculitis [30]. However, so far there are no data on the contribution
of endothelial viral receptors of the innate immune system, which are able to bind
nucleic acids of viral origin and elicit proinflammatory responses, to HCV-
associated vasculitis. There is large body of evidence for several receptors for
dsRNA existing in eukaryontic cells, including TLR3 and the cytosolic receptors
RIG-I and MDA5 [31, 32]. In human and murine endothelial cells, the synthetic
analogue of dsRNA of viral origin, poly (I:C), is known to have various
proinflammatory effects [33, 34, 35]. These effects depend on the origin of the
endothelial cells as to species and vascular bed [36].
In the present manuscript we demonstrate for the first time that HCV-RNA
isolated from a patient with HCV-associated MC significantly induces both
expression and synthesis of a variety of mediators known to be relevant to the
initiation and propagation of inflammation in viral disease, and the adhesion
molecule ICAM-1. We infer that HCV directly promotes activation, adhesion and
infiltration of inflammatory cells into the vessel wall by activation of viral
receptors of the innate immune system in endothelial cells. Due to the ability of
HCV to both recruit leucocytes to the endothelium and sustain local
inflammatory responses, any relevant viremia could cause a clinically apparent
vasculitis. As a matter of fact, in mice systemically treated with the synthetic
analogue of viral dsRNA poly (I:C), we found a significant reduction in leukocyte
rolling velocity as well as an increase in leukocyte adhesion to the vessel wall,
which was paralleled by a significantly increased extravasation of leukocytes in
vivo. In addition, poly (I:C) induces the expression of the corresponding receptor
TLR3 in vivo and hereby allows for amplification of all of the aforementioned
responses upon viral infection. These findings underscore the relevance of direct
effects of circulating nucleic acids of viral origin on the pathogenesis of vasculitis.
In vitro stimulation of viral receptors with poly (I:C) causes a time- and dose-
dependent induction of IL-6, IL-8, RANTES, MCP-1, IP-10 and IFN-b as well as
MCSF and the adhesion molecules ICAM-1 and VCAM-1 in HMEC. Using
knockdown experiments with siRNAs specific for the viral receptors TLR3, RIG-I
and MDA5, we provide evidence for a mutual dependence of the regulation of
viral RNA receptors upon ligand binding as well as for a selective mediation of the
poly (I:C)-dependent induction of proinflammatory genes by TLR3. We presume
these effects to promote vascular inflammation in vivo once circulating HCV-
RNA binds to viral receptors of the innate immune system, a process which does
not presuppose viral entry and replication in endothelial cells. Even though not
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classifying as primary target cells of HCV, however, HMEC express CD81
tetraspanin, the scavenger receptor class B type I, tight junction proteins and LDL
receptors, all of them able to mediate HCV entry into hepatic and non-hepatic
cells [37, 38]. Furthermore, human brain endothelial cells have already been found
to express functional receptors that support HCV entry and replication [39]. The
contribution of a direct viral infection of HMEC to extrahepatic manifestations of
HCV infection thus merits future attention.
An important mediator involved in both the early antiviral response and a
variety of immune and autoimmune phenomena associated with viral diseases is
tumor necrosis factor alpha (TNFa). Referring to vasculitis in particular, TNFa
is known to partly mediate the prothrombotic conditions implicated by systemic
inflammation, and small vessel occlusion results in an amplification of local
inflammatory responses. In this manuscript we show that TNFa adds
significantly to the proinflammatory effects of viral RNA on endothelial cells and
therefore plays an important role in the initiation and propagation of vascular
manifestations of HCV-infection. In addition, we show for the first time that
HCV-RNA containing cryoprecipitates significantly induce the endothelial
expression of TNFa and TNFa receptor subtype 2 (TNFR2) in vitro and we
provide evidence that leucocyte adhesion and transmigration in response to
activation of viral RNA receptors in vivo seem to depend on the expression of
functional TNFR2. While TNFR1 is constitutively expressed in most tissues, the
expression of TNFR2 is highly regulated and mediates tissue damage in chronic
inflammation; this effect possibly depends on the induction of endogenous
TNFa via activation of TNFR2, which increases local TNFa concentrations and
subsequently activates TNFR1 [40]. Our observation of a selective induction of
TNFR2 by HCV-RNA and the requirement of functional TNFR2 for
endothelium-dependent leucocyte activation in poly (I:C)-treated mice would
again favour the therapeutic use of a TNFR2-specific antagonist, already
advocated for its potential to downregulate excessive TNFa signaling in
uncontrolled inflammatory processes without affecting beneficial TNFa effects.
In view of the fact that the treatment of HCV-associated vasculitis is largely
empirical, this alternative therapeutic approach might be of particular clinical
relevance. Indeed, the current standard therapy is antiviral treatment with peg-
inteferon plus ribavirin without use of systemic immunosuppressive agents
[6, 41]; for MC, a therapy with Rituximab, a monoclonal antibody against the
CD 20 antigen expressed on B cells, can be considered in patients with severe
clinical manifestations including vasculitis, glomerulonephritis or neuropathy
[42].
In summary, our results demonstrate that endothelial cells actively participate
in immune mediated vascular inflammation caused by viral infections. Activation
of the pattern-recognition receptor TLR3 by HCV-RNA and poly (I:C) induces
the expression of proinflammatory cytokines, chemokines and adhesion molecules
and might thereby directly contribute to viral disease-associated vasculitis. TNFa
adds significantly to the proinflammatory effects of viral RNA on endothelial cells.
In vivo, poly (I:C) enhances leucocyte adhesion and transmigration, an effect
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which seems to selectively depend on subtype specific signalling of TNFa via
TNFR2.
Supporting Information
Figure S1. Effect of poly (I:C) on the expression of cytokines, chemokines, type
I interferons, MCSF and adhesion molecules on HMEC. HMEC were stimulated
without (basal) and with poly (I:C) (10 mg/ml) for different time intervals (3, 6, 9,
12, 24, 48 hours) and mRNA expression of IL-6 (A), IL-8 (C), IP-10 (E), RANTES
(G), MCP-1 (H), IFN-a (I), IFN-b (J), MCSF (K), ICAM-1 (L) and VCAM-1 (N)
was analyzed by RT-PCR. Protein synthesis of selected factors IL-6 (B), IL-8 (D)
and IP-10 (F) was confirmed by ELISA. Protein synthesis of ICAM-1 (M) and
VCAM-1 (O) was confirmed by FACS. Surface expression of E-selectin (P) and P-
selectin (Q) was analyzed in HUVEC by FACS. Results are given as means ¡ SD
of three experiments done in parallel for each condition and rRNA served as the
reference gene. Comparable results were obtained in two series of independent
experiments. (R) HMEC were stimulated with poly (I:C) (10 mg/ml) for different
time intervals (0, 3, 6, 9, 12, 24, 48 hours) and cell proliferation was analyzed by
the MTT assay. Each bar represents a mean ¡ SD of 24 parallel incubations for
each condition. Comparable results were obtained in four series of independent
experiments. Statistically significant differences to the control are depicted with *
5p#0.05.
doi:10.1371/journal.pone.0113351.s001 (EPS)
Figure S2. Effects of transfection with siRNA for TLR3, RIG-I and MDA5 on
poly (I:C) induced gene expression. HMEC were transfected with siRNA for
TLR3, RIG-I and MDA5 as well as unspecific RNA as negative control as described
in Materials and Methods and stimulated with poly (I:C) (10 mg/ml) for 12 hours.
Expression of TLR3 (A), RIG-I (B), MDA5 (C) IL-6 (D), RANTES (E), MCP-1
(F), IP-10 (G), IFN-b (H), ICAM-1 (I) and VCAM-1 (J) was analyzed by RT-
PCR. Results are given as means ¡ SD of three experiments done in parallel for
each condition and rRNA served as the reference gene. Comparable results were
obtained in two series of independent experiments. Statistically significant
differences to the control are depicted with * 5p#0.05.
doi:10.1371/journal.pone.0113351.s002 (EPS)
Figure S3. Effect of TNFa on the expression of cytokines, chemokines and
adhesion molecules. HMEC were stimulated with TNFa for different time intervals
(3, 6, 9, 12, 24 hours) and mRNA expression of IL-6 (A), IL-8 (C), IP-10 (E),
RANTES (G), MCP-1 (H), IFN-b (I), MCSF (J), ICAM-1 (K) and VCAM-1 (L) was
analyzed by RT-PCR. Protein synthesis of IL-6 (B), IL-8 (D) and IP-10 (F) was
analyzed by ELISA. Results are given as means ¡ SD of three experiments done in
parallel for each condition and rRNA served as the reference gene. Comparable
results were obtained in two series of independent experiments. Statistically
significant differences to the control are depicted with * 5p#0.05, ** 5p#0.01.
doi:10.1371/journal.pone.0113351.s003 (EPS)
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Figure S4. Amplification of poly (I:C)-dependent induction of viral receptors
and TNF receptor 2 by TNFa. HMEC were grown in culture medium for
24 hours and additionally incubated in medium (basal) for different time
intervals (6, 12, 24 hours) or grown in culture medium for 24 hours and
additionally incubated with TNFa (TNFa) for different time intervals (6, 12,
24 hours) or incubated with poly (I:C) for 24 hours and then grown in medium
(poly (I:C)) or stimulated with TNFa (poly (I:C) + TNFa) for different time
intervals (6, 12, 24 hours). Expression of TLR3 (A), RIG-I (B) and MDA5 (C) as
well as TNFR2 (D) was analyzed by RT-PCR. Results are given as means ¡ SD of
three experiments done in parallel for each condition and rRNA served as the
reference gene. Comparable results were obtained in two series of independent
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